The Regulator

More than $1 billion a year: that is the administrative cost hospitals say the federal 340B rebate pilot would add, against $537 million in the government’s own estimate, and drugmakers moved last week to join the fight. The 340B program lets safety-net hospitals buy certain drugs at discounted prices. Under the pilot, the Health Resources and Services Administration (HRSA) would have hospitals pay the higher price up front and then claim rebates from manufacturers, covering 21 drugs from 10 manufacturers (Eliquis, Jardiance, Farxiga and Januvia among them), starting January 1, 2027. The American Hospital Association (AHA), the Maine Hospital Association and four safety-net hospitals sued in federal court in Maine on October 9 to block it. On October 14, AbbVie, Bristol Myers Squibb and Boehringer Ingelheim moved to intervene (join the case as parties), and the drug industry trade group PhRMA filed its own motion October 15. They argue HRSA cannot fully represent them because they face the duplicate-discount losses and civil penalties. Both filings reportedly note the court denied similar bids in the first round of this litigation in December 2025, and that the First Circuit vacated that order September 25. The court has not ruled on the motions or on the hospitals’ request to block the pilot. Who it hits: 340B hospitals, which would carry the cash-flow burden until rebates arrive, and the 10 manufacturers that must build and fund the rebate claim systems. This continues our October 11 coverage of the hospitals’ suit. We could not open the court filings or HRSA’s pilot page, so the figures and dates rest on trade reporting. Confidence: Med on the filing dates and cost figures; Low on how the court will rule. Sources: Becker’s Hospital Review on the intervention motions, 340B Report, Medical Daily on the cost estimates.

October 23: that is the last day to petition against five companies that decide No Surprises Act payment disputes between insurers and out-of-network providers. The Centers for Medicare & Medicaid Services (CMS) opened a five-business-day petition window October 16 for the independent dispute resolution (IDR) entities Maximus Federal Services, ProPeer Resources, C2C Innovative Solutions, Medical Evaluators of Texas ASO, and Federal Hearings and Appeals Services, which are up for recertification. Providers, facilities, air ambulance providers, plans, issuers, state regulators and members of the public may file, using the form at the CMS petition portal, and must show the entity failed to satisfy the No Surprises Act requirements. Petitioners get an emailed acknowledgment within 10 days, the entity can respond, and a final certification decision follows. CMS says it will post more entities for petition as it reviews applications, and the page does not name who makes the final call. Who it hits: any plan or provider with an open out-of-network dispute before these arbiters, since a decertified entity’s pending cases are a question the page does not answer. Confidence: High on the window and entity list. Sources: CMS, petitions to deny IDR entity certification.

CMS will not deny inpatient rehabilitation claims solely because the first team meeting was late, from October 1, 2026 through March 31, 2027. The fiscal 2027 inpatient rehabilitation facility (IRF) payment rule requires the initial interdisciplinary team meeting within four days of admission. For six months, Medicare Administrative Contractors will apply the fiscal 2026 timing standard and will not deny or non-affirm a claim on timing alone, as long as a team meeting happens at least weekly for the whole stay. All other coverage and documentation requirements still apply. The AHA had objected that the rule described the four-day clock inconsistently. Who it hits: rehabilitation hospitals and rehab units billing Medicare, which get until the end of March 2027 to rebuild their workflow before the stricter test can be enforced. The AHA’s account is dated October 16; we did not retrieve CMS’s own notice, so confirm the wording on CMS’s IRF page. Confidence: Med. Sources: CMS inpatient rehabilitation facility page, Federal Register, FY 2027 IRF payment final rule (2026-15652), supplemental: American Hospital Association.

5.0%: that is the share of flu tests that came back positive in the first Centers for Disease Control and Prevention (CDC) report of the 2026-27 season, up from 3.9% a week earlier. For the week ending October 10, 2,270 of 45,331 specimens were positive, and 97.9% of positives were influenza A. Outpatient visits for influenza-like illness were 2.1%, below the 2.9% national baseline. Hospitals recorded 4,024 flu admissions through the national hospital reporting network, a rate of 1.2 per 100,000, stable from the prior week, and no pediatric deaths have been reported this season. CDC calls activity low but rising, higher than usual for this point in the year but within expected variation, with the most activity on the West Coast. So what: it is early, but staffing and vaccine-supply decisions for hospitals and pharmacies are being made against a season that has started slightly ahead of a typical year. Confidence: High on the figures. Sources: CDC FluView, week 40.

The Office of Personnel Management (OPM) asked for comment on a new online portal for family-member documentation in the Federal Employees Health Benefits (FEHB) program. The notice was published in the Federal Register today and comments close December 18, 2026. It would be a new information collection, the “FEHB Protection Act Portal.” We could read only the abstract, not the burden estimate or the portal’s rules, so the number of enrollees affected and any coverage consequence for families that cannot document eligibility are not confirmed here. Confidence: High on the dates; Low on scope. Sources: Federal Register, OPM FEHB Protection Act Portal notice (2026-21380).